NA Proactive news snapshot: Vuzix, Genprex, LexaGene, The Greenrose Holding Company, Bhang UPDATE …

A glance at some of the day’s highlights from the Proactive Investors US and Canada newswires

Vuzix Corporation (NASDAQ:VUZI) revealed that the company’s smart glasses are now in initial deployment in over 40 warehouses to support a Fortune 50 online retailer’s supply chain operations following the successful completion of a proof-of-concept that was completed earlier last year in one warehouse. “Across the board, Vuzix is investing time and resources to support our largest customers within the retail, warehousing and logistics vertical that have come to Vuzix with specific use cases and operational challenges that they would like to solve with smart glasses,” Vuzix founder CEO Paul Travers said in a statement. “It is great to see Vuzix smart glasses getting put to work on a daily basis with this Fortune 50 customer, which represents just one of many exciting opportunities within this vertical, and we look forward to working with this customer to expand both their depth and breadth of Vuzix smart glasses usage,” he added.

Vuzix Corporation (NASDAQ:VUZI) has announced it would jointly demonstrate TeamViewer Frontline, an AR platform, with TeamViewer at CES 2022 in Las Vegas this week. The pairing of TeamViewer Frontline with Vuzix smart glasses, known across industry verticals for offering the optimal combination of all-day comfort and performance, means many more organizations throughout the value chain can now deliver on the promise of a truly connected workforce. The company said it continues to expand its partnership with TeamViewer to focus on jointly developing strategic accounts across select verticals including retail, logistics, and manufacturing.

Genprex Inc. revealed that the US Food and Drug Administration (FDA) granted Fast Track designation to the company’s lead drug candidate, REQORSA Immunogene Therapy, in combination with Merck & Co’s Keytruda in patients with stage III or IV non-small cell lung cancer (NSCLC), where disease progressed after treatment with Keytruda. The Austin, Texas-based clinical-stage gene therapy company said that in the first quarter of 2022, it plans to initiate its Acclaim-2 clinical trial, which is an open-label, multicenter Phase 1/2 clinical trial evaluating REQORSA in combination with Keytruda, for this patient population.

LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, announced three additional purchase orders for MiQLab Systems from veterinary clinics in Michigan, Minnesota, and New York. In a statement, Julie Griggs, who is global director of sales at LexaGene, said: “My team is diligently engaged with numerous veterinary practices, both private and corporate. Many of the veterinarians we have spoken to share our excitement over the value of in-clinic PCR testing and the capabilities that the MiQLab System can provide to their practices. “It is gratifying to welcome 2022 with a strong start and continue our momentum as we work on closing additional sales.”

The Greenrose Holding Company (OTCQX:GNRS) Inc, which plans to become a multistate cultivator and producer of cannabis products, revealed that it closed its previously announced acquisition of the assets of Arizona-based True Harvest LLC. Under the terms of deal, Greenrose paid a consideration of $57.6 million at the close, consisting of $12.5 million in cash, $23 million in the form of a convertible note, $4.6 million in assumed debt, and $17.5 million in shares of the company’s stock. “Contingent upon True Harvest achieving a certain price point per pound of cannabis flower relative to total flower production within 36 months of the closing of the transaction, Greenrose will pay additional consideration of up to $35 million in the form of an earnout, payable in shares,” said Greenrose.

Harbor Custom Development Inc said it has closed a $19,129,000 construction loan with Broadmark Realty Capital for the 126 unit first phase of its 228 unit Olympic Sunset View Apartment project in Belfair, Washington. Located in North Mason County, Washington the 228-unit garden-style apartment complex currently under construction, is conveniently situated adjacent to highway SR 3 and provides views of Puget Sound and the Olympic Mountains. Belfair is approximately a 15-minute drive to downtown Bremerton, the Seattle ferry, and the Kitsap Naval Base, a major contributor to a robust defense economy with approximately 40,000 employees tied to the military and defense industry in the area. Residents of the Olympic Sunset View Apartments will enjoy easy access to outdoor recreation highlighted by Belfair State Park a convenient 5-minute drive from the project offering year-round camping on 3,720 feet of saltwater shoreline at the southern end of Hood Canal, the company said.

Bhang Inc (CSE:BHNG, OTCQB:BHNGF) has announced a grant of options to purchase an aggregate of 4,575,000 subordinate voting shares of the company to certain directors, officers, employees and consultants of the company. The stock options are exercisable at a price of $0.10 per share until December 31, 2024. Upon issuance, 3,165,000 stock options vested immediately, 330,000 stock options will vest on June 30, 2022, 330,000 stock options will vest on November 1, 2022, and 750,000 stock options to vest in equal 250,000 tranches on March 31, 2022, June 30, 2022, and September 30, 2022. Bhang also granted an aggregate of 7,362,500 restricted stock units (RSUs) to certain directors, officers, employees and consultants of the company. Upon issuance, 2,062,500 of the RSUs vested immediately, 4,970,000 will vest on January 4, 2022, 165,000 will vest on June 30, 2022, and 165,000 will vest on November 1, 2022. Upon vesting, the subordinate voting shares underlying the RSUs will be issued at a deemed price of $0.08 per share. All stock options and RSUs were granted in accordance with the company’s 2019 Equity Incentive Plan. Bhang also announced the issuance of 3,194,000 subordinate voting shares at a price of $0.08 per share to Jamie L. Pearson, its president and chief executive officer, in satisfaction of the company’s obligation under the terms of the employment agreement with Ms. Pearson.

Vicinity Motor Corp has announced that certain eligible directors have requested that their respective director’s remuneration for the calendar year 2021 be paid in deferred share units (DSUs) and accordingly, the company has granted 40,713 DSUs in connection with directors’ remuneration for Q4.

Falcon Gold Corp (TSX-V:FG, OTC:FGLDF) said its board of directors, in compliance with the company’s stock option plan, has granted 2.2 million incentive stock options exercisable for up to five years at a price of 5 cents a unit to directors, officers and consultants of the company.

Great Atlantic Resources Corp (TSX-V:GR) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced on November 17, 2021, which will see the issue of 3,741,250 flow-through shares at a purchase price of 40 cents per flow-through share together with 3,741,250 share purchase warrants with an exercise price of 75 cents for a three-year period with 12 placees.

Ximen Mining Corp (TSX-V:XIM, OTCQB:XXMMF) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced on December 1, 2021, which will see the issue of 1.04 million flow-through shares at a purchase price of 22 cents per flow-through share together with 1.04 million share purchase warrants with an exercise price of 35 cents for a three-year period with 10 placees.

INDVR Brands Inc announced that it has published its Financial Statements and MD&A for nine months ended October 31, 2021. The Financial Statements and accompanying MD&A are available on SEDAR.

Todos Medical Ltd. (OTCQB:TOMDF) has announced that its president & CEO Gerald Commissiong will be presenting at the upcoming Emerging Growth Conference on January 5, 2022, at 12.00pm EST. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with Commissiong in real-time. Investors can register via the following link: 

Source link